EN
登录

Weiyun AI Snared Over 100 Million Yuan A Round Financing

Mailman 2019-09-18 21:56

According to PEdaily, on September 18, 2019, Jiangsu Weiyun Artificial Intelligence Co., Ltd. ( Weiyun AI), the first digital dental C2M industrial Internet enterprise based on artificial intelligence technology, announced that it had received A round financing of over 100 million yuan, led by AlphaX Partners.


Weiyun AI provides clinical dental products through customized robots and smart unmanned factories. The company is the only domestic company, which combines medical health with artificial intelligence, with laser vision and robot technology.  Weiyun AI is committed to building a digital dental Internet online service platform for enterprises.


Weiyun AI’s customized dental service industrial Internet platform and intelligent cloud factory can shorten the implementation cycle of denture replacement and dentistry to 1-2 days, and greatly improve the utilization rate of expensive consumables. 


In addition, through unique software and hardware, cloud, intelligent factory and supply chain, Weiyun AI creates a C2M ecology, providing more accurate and technology for medical institutions, hospitals, and clinics. It enables small clinics to use advanced equipment and improves treatment efficiency. For patients, it can shorten treatment time and make their treatment more comfortable.


Until now, Weiyun AI has acquired nearly 100 patents of completely independent intellectual property rights. The company’s service has covered 20,000 clinics in China and started clinical cooperation with several first-class hospitals.


>>>>

About AlphaX Partners


AlphaX Partners is an early-stage venture capital firm investing in startups in technology sector, with its missions including helping entrepreneurs build disruptive companies and providing an active hands-on investment approach and proprietary deal sourcing.

Mailman

共发表文章3245篇

最近内容
查看更多
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09